Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gemcitabine (gemzar) (1 trial)
lcl-161 (1 trial)
paclitaxel (taxol) (1 trial)
Pancreatic Neoplasms (Phase 1)
Trials (1 total)
Trial APIs (3 total)